ArticleFrontiers in medicine2025
A clinical prediction model for schizophrenia based on machine learning algorithms.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence approaches for schizophrenia prediction and its biomarkers using medical imaging data.Frontiers in psychiatry · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop an auxiliary diagnostic tool for schizophrenia based on multiple test variables using different machine learning algorithms. Methods: This retrospective study used routinely collected peripheral blood biochemical indicators, along with demographic data, to develop a diagnostic model for first-episode schizophrenia. A total of 180 patients with first-episode schizophrenia between January and August 2024, and 214 healthy controls as a population undergoing routine medical examinations during the same period. Data on age, gender, and various blood test results were collected. The dataset was divided into a training set (70%; Results: Arg, TP, ALP, HDL, UA, and LDL were ultimately identified as significant predictors through Univariate logistic regression combined with the Boruta and LASSO algorithms. The Random Forest algorithm outperformed other machine learning models, achieving an AUC of 1.00 for the training set and 0.877 for the validation set. However, due to the risk of overfitting, we ultimately selected the multivariate logistic regression model as the final model for our study and constructed nomograms. Conclusion: In this study, an auxiliary diagnostic tool for schizophrenia was established using machine learning algorithms combined with routine blood indicators. The logistic regression model demonstrated good performance and can serve as a diagnostic aid for schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.